Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Sales (2016 - 2025)

Historic Return on Sales for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to 0.09%.

  • Amphastar Pharmaceuticals' Return on Sales fell 1200.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.2% for FY2024, which is 100.0% down from last year.
  • Amphastar Pharmaceuticals' Return on Sales amounted to 0.09% in Q3 2025, which was down 1200.0% from 0.18% recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Return on Sales' 5-year high stood at 0.28% during Q3 2021, with a 5-year trough of 0.04% in Q1 2021.
  • For the 5-year period, Amphastar Pharmaceuticals' Return on Sales averaged around 0.18%, with its median value being 0.18% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 2300bps in 2021, then crashed by -1400bps in 2022.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Return on Sales stood at 0.17% in 2021, then skyrocketed by 31bps to 0.22% in 2022, then dropped by -14bps to 0.19% in 2023, then fell by -25bps to 0.14% in 2024, then tumbled by -36bps to 0.09% in 2025.
  • Its Return on Sales stands at 0.09% for Q3 2025, versus 0.18% for Q2 2025 and 0.15% for Q1 2025.